Search
About WifOR
Research
Health
Burden of Disease
Health Economy Reporting
Health ROI Assessor
Social Impact
Sustainability
Economic and R&D Footprint
Environmental Footprint
Impact Valuation
Benchmarks
Value Factors
Scope 3 Assessment
Social Hotspot Analysis
WISIT – the WifOR Institute Sustainability Impact Tool
Labor Market
Big Data Skills Analysis
Employer Attractiveness Analysis
Diversity, Equity & Inclusion
Diversity study
Skilled Labor Analysis
Data packages
GHG Emission Factors
Spend-based Multipliers for Sustainability Analysis
Value Factors
Publications
Newsroom
Career
DE
EN
Contact
Latest publications
Journal publication
Foteini Tsotra, Ankur Malhotra, Dr. Platon Peristeris, Ioannis Athanasiou, Dr. Malina Müller, Dr. Giovanni Bader
05/2024
Health and Productivity Benefits with Early Intensified Treatment in Patients with Type 2 Diabetes: Results from Korea
Method paper
Dr. Richard Scholz, Tabea Dorndorf, Jasmin Tesch, Robert Köster, Dr. Daniel Croner, Dr. Zarko Kalamov, Jana Setzer
05/2025
Impact Measurement Using WifOR’s Sustainability Footprint Method
Study
Adnan Atitallah, Jennifer Branner, Prof. Dr. Dennis A. Ostwald, Dr. Rebecca Grün, Dr. Maren Herrlitz, Dr. Eva Levi, Davide Lovera, Dr. Malina Müller, Dr. Platon Peristeris, Lena Steinbeck
08/2025
The Value of Investing in Innovative Medicines: Socioeconomic Burden and Annual Social Impact of Roche Treatments for HER2+ Breast Cancer, Multiple Sclerosis and Retinal Disease
Library
Research area
Career
Health
Labor Market
Newsletter
Sustainability
Publication type
Conference poster
Journal publication
Method paper
Scientific article
Study
Study
2025
Economic Evaluation of Early Intervention in Chronic Limb Threatening Ischaemia (CLTI)
Foteini Tsotra, Prof. Dr. Jos C. van den Berg, Finbar Dolan, Dr. Jasper Ubels, Katrin Ostwald, Lena Steinbeck, Dr. Malina Müller
Study
2025
Moving Upstream: Disease Prevention as Strategic Opportunity for Irish Medtech Innovation
Irish Medtech Skillnet
Conference poster
2025
Are European Healthcare Systems Prepared for a Potential Rapid Rise in Radioligand Therapy Eligible Patient Numbers?
Leonhard Schaetz, Margarida Goulart, Roberta Cirillo, Dr. Diego Hernandez, Dr. Platon Peristeris, Andreas Poschenreider, Panagiota Papaioannou, Panos Kanavos, Christian la Fougère, Uwe Holzwarth
Study
2025
The Value of Investing in Innovative Medicines: Socioeconomic Burden of HER2+ Breast Cancer, Diabetic Macular Edema, Age-related Macular Degeneration and Annual Social Impact of Roche’s Treatments for Diseases in LATAM
Adnan Atitallah, Prof. Dr. Dennis A. Ostwald, Dr. Rebecca Grün, Dr. Maren Herrlitz, Dr. Eva Levi, Davide Lovera, Dr. Malina Müller, Dr. Platon Peristeris
Study
2025
The Value of Investing in Innovative Medicines: Socioeconomic Burden of HER2+ Breast Cancer and Annual Social Impact of Roche’s Treatments for the Disease in Africa
Adnan Atitallah, Prof. Dr. Dennis A. Ostwald, Dr. Rebecca Grün, Dr. Maren Herrlitz, Dr. Eva Levi, Davide Lovera, Dr. Malina Müller, Dr. Platon Peristeris
Study
2025
The Value of Investing in Innovative Medicines: Socioeconomic Burden and Annual Social Impact of Roche Treatments for HER2+ Breast Cancer, Multiple Sclerosis and Retinal Disease
Adnan Atitallah, Jennifer Branner, Prof. Dr. Dennis A. Ostwald, Dr. Rebecca Grün, Dr. Maren Herrlitz, Dr. Eva Levi, Davide Lovera, Dr. Malina Müller, Dr. Platon Peristeris, Lena Steinbeck
‹
1
2
3
4
…
19
›
Interested in our newsletter?
Register
